Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone-marrow stem cells as a source for cell therapy.

Ray C-J Chiu1

  • 1Professor of Surgery, Division of Cardiothoracic Surgery, McGill University, Montreal, Canada. ray.chiu@mcgill.ca

Heart Failure Reviews
|July 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Marrow stromal cells for cell-based therapy: the role of antiinflammatory cytokines in cellular cardiomyoplasty.

The Annals of thoracic surgery·2010
Same author

Microencapsulation to reduce mechanical loss of microspheres: implications in myocardial cell therapy.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2010
Same author

Marrow stromal cells as universal donor cells for myocardial regenerative therapy: their unique immune tolerance.

The Annals of thoracic surgery·2008
Same author

Cellular cardiomyoplasty: routes of cell delivery and retention.

Frontiers in bioscience : a journal and virtual library·2007
Same author

From "spongy" and "cold" hearts to cellular cardiomyoplasty: tales of Canadian contribution to global cardiac surgery.

World journal of surgery·2007
Same author

Xenogeneic cell transplant: fact or fancy?

International journal of cardiology·2004
Same journal

Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.

Heart failure reviews·2026
Same journal

Beyond vasodilation: sotatercept and the remodeling hypothesis in hfpef-associated pulmonary hypertension.

Heart failure reviews·2026
Same journal

Beyond the right ventricle: left heart involvement in pulmonary arterial hypertension.

Heart failure reviews·2026
Same journal

Left ventricular non-compaction in heart failure: contemporary perspective on diagnostic challenges and treatment opportunities.

Heart failure reviews·2026
Same journal

Correction to: Left atrial shunting devices: why, what, how, and… when?

Heart failure reviews·2026
Same journal

Cardiac microcurrent therapy in heart failure: Mechanistic rationale, early clinical evidence, and future directions.

Heart failure reviews·2026
See all related articles

Adult stem cells from bone marrow can become heart cells and repair cardiac damage. These cells may offer a universal donor option for treating heart failure.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Biology
  • Stem Cell Therapy

Background:

  • Bone marrow stroma harbors cells capable of differentiating into cardiomyocytes.
  • These cells can integrate into the myocardium in vivo, responding to microenvironmental cues.
  • They are implicated in the natural healing of myocardial injury, migrating from bone marrow to damaged sites.

Purpose of the Study:

  • To investigate the potential of bone marrow-derived cells for myocardial repair.
  • To explore their therapeutic application in cardiac damage and heart failure.
  • To examine the immuno-tolerance of these adult stem cells for potential universal donor use.

Main Methods:

  • In vitro differentiation of bone marrow stromal cells towards a cardiomyocyte phenotype.

Related Experiment Videos

  • In vivo implantation studies in myocardial injury models.
  • Analysis of cell homing, integration, and functional contribution to cardiac repair.

    • Main Results:

    • Bone marrow stromal cells successfully differentiated and expressed cardiomyocyte markers in vitro.
    • Implanted cells integrated into the myocardium and contributed to repair following injury.
    • Evidence suggests these cells are recruited from bone marrow and traffic to injured cardiac tissue.

    Conclusions:

    • Adult stem cells from bone marrow possess the potential for cardiac regeneration.
    • These cells may serve as a therapeutic strategy for myocardial repair and heart failure treatment.
    • Further research into their immuno-tolerance could establish them as universal donor cells for regenerative therapy.